# Safety of Microporous Annealed Particle (MAP) Wound Matrix in Patients With Clean Surgical Wounds.

> **NCT06600152** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Tempo Therapeutics** · enrollment: 40 (actual)

## Conditions studied

- Wound Heal

## Interventions

- **DEVICE:** MAP Wound Matrix
- **DEVICE:** DuoDerm

## Key facts

- **NCT ID:** NCT06600152
- **Lead sponsor:** Tempo Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-26
- **Primary completion:** 2026-08-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06600152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06600152, "Safety of Microporous Annealed Particle (MAP) Wound Matrix in Patients With Clean Surgical Wounds.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06600152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*